Method for preparing combretastatins

Details for Australian Patent Application No. 2003260026 (hide)

Owner Aventis Pharma S.A.

Inventors Lavigne, Michel; Casimir, Jean-Paul; Mutti, Stephane; Malejonock, Irina

Agent Watermark

Pub. Number AU-B-2003260026

PCT Number PCT/FR03/01117

PCT Pub. Number WO2003/084919

Priority 02/04499 11.04.02 FR

Filing date 9 April 2003

Wipo publication date 20 October 2003

Acceptance publication date 3 January 2008

International Classifications

C07D 263/06 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

C07C 213/02 (2006.01) Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton

C07C 217/84 (2006.01) Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton

C07D 263/04 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

Event Publications

20 November 2003 Complete Application Filed

  Priority application(s): 02/04499 11.04.02 FR

27 November 2003 Application Open to Public Inspection

  Published as AU-B-2003260026

3 January 2008 Application Accepted

  Published as AU-B-2003260026

22 May 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003260027-POSITION ESTIMATION AND DEMAGNETIZATION DETECTION OF A PERMANENT MAGNET MOTOR

2003260025-METHOD FOR THE PREVENTION AND/OR TREATMENT OF ATHEROSCLEROSIS